Eli Lilly Weight Loss Drug Jim Cramer

Weight Loss Drug Demand Drives Eli Lilly Sales

Eli Lilly (NYSE:LLY) Speeds Up Weight Loss Drug Data Release

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s leader can become

Insider Monkey on MSN · 18d

Jim Cramer Says ‘Eli Lilly and Company (LLY)’s Drug Is Superior In Terms Of Weight Reduction At The Same Dose’

We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks Jim Cramer recently discussed.

Reuters · 17h

Lilly reassures investors that weight-loss drug demand is strong, shares rise

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular diabetes and weight-loss treatments in new markets.

CNBC on MSN6d

Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

CNBC's Jim Cramer on Friday walked investors through an earnings-heavy week, highlighting reports from Amazon, Alphabet, Eli ...

Yahoo23d

Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow

Asks Expert Jim Cramer on Verizon Communications Inc. (VZ): ‘I Don’t Like To Buy A Stock Just For The Yield When It Doesn’t Have Growth’ The days of US stock outperformance are over as ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Weight Loss Drug Demand Drives Eli Lilly Sales

Trending now